Related Experiment Video
Updated: Aug 1, 2025

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Poor utilization of palliative care among Medicare patients with chronic limb-threatening ischemia
Mimmie Kwong1, Ganesh Rajasekar2, Garth H Utter3
1Department of Surgery, Division of Vascular Surgery, University of California Davis School of Medicine, Sacremento, CA.
Insights
Palliative care is underutilized in Medicare patients with chronic limb-threatening ischemia (CLTI), a condition with high mortality. Evaluations, when provided, often occur near death, indicating a potential misuse of palliative care services.
Area of Science:
- Vascular Medicine
- Palliative Care
- Health Services Research
Background:
- Chronic limb-threatening ischemia (CLTI) is associated with high annual mortality.
- Timely palliative care intervention can benefit patients with CLTI.
- Understanding palliative care utilization in this population is crucial.
Purpose of the Study:
- To characterize the use of palliative care among Medicare beneficiaries with CLTI.
- To identify factors associated with receiving palliative care evaluations in CLTI patients.
Main Methods:
- Retrospective analysis of Medicare data from 2017-2018.
- Identification of CLTI patients based on diagnosis codes.
- Analysis of palliative care consultations using ICD-10-CM Z51.5 code.
- Calculation of time intervals and assessment of demographic/comorbidity associations.
Main Results:
- Only 7.4% of 12,133 CLTI patients received palliative care evaluation.
- Palliative care patients were more likely to be dual-eligible and have more comorbidities.
- Factors associated with evaluation included age, dual eligibility, various malignancies, heart failure, complicated diabetes, dementia, and renal failure.
- Palliative care was received by 27.8% of deceased patients, often shortly before death, versus 3.2% of living patients.
Conclusions:
- Palliative care services are rarely utilized by Medicare patients with CLTI.
- Patient age, medical complexity, and socioeconomic factors influence palliative care consultation.
- Palliative care evaluations in CLTI patients appear to be predominantly used as end-of-life care rather than early intervention.
Objective:
Patients with chronic limb-threatening ischemia (CLTI) experience high annual mortality and would benefit from timely palliative care intervention. We sought to better characterize use of palliative care among patients with CLTI in the Medicare population.
Methods:
Using Medicare data from 2017 to 2018, we identified patients with CLTI, defined as two or more encounters with a CLTI diagnosis code. Palliative care evaluations were identified using ICD-10-CM Z51.5 "Encounter for palliative care." Time intervals between CLTI diagnosis, palliative consultation, and death or end of follow-up were calculated. Associations between patient demographics, comorbidities, and palliative care consultation were assessed.
Results:
A total of 12,133 Medicare enrollees with complete data were categorized as having CLTI. Of these, 7.4% (894) underwent a palliative care evaluation at a median of 170 days (interquartile range, 45-352 days) from their CLTI diagnosis. Compared with those who did not undergo evaluation, palliative patients were more likely to be dual eligible for Medicaid (45.2% vs 38.1%; P < .001) and had more comorbid conditions (P < .001). After controlling for gender and race, age (odds ratio [OR], 1.03; 95% confidence interval [CI], 1.02-1.04), dual eligibility (OR, 1.40; 95% CI, 1.22-1.62), solid organ malignancy (OR, 2.82; 95% CI, 1.92-4.14), hematologic malignancy (OR, 2.24; 95% CI, 1.27-3.98), congestive heart failure (OR, 1.44; 95% CI, 1.15-1.88), complicated diabetes (OR, 1.35; 95% CI, 1.11-1.65), dementia (OR, 1.32; 95% CI, 1.04-1.66), and severe renal failure (OR, 1.56; 85% CI. 1.24-1.98) were independently associated with palliative care evaluation. During mean follow up of 410 ± 220 days, 16.9% (2044) of patients died at a mean of 268 (±189) days after their CLTI diagnosis. Among living patients, only 3.2% (325) underwent palliative evaluation. Comparatively, 27.8% (569) of patients who died received palliative care at a median of 196 days (interquartile range, 55-362 days) after their diagnosis and 15 days (interquartile range, 5-63 days) prior to death.
Conclusions:
Despite high mortality, palliative care services were rarely provided to Medicare patients with CLTI. Age, medical complexity, and income status may play a role in the decision to consult palliative care. When obtained, evaluations occurred closer to time of death than to time of CLTI diagnosis, suggesting misuse of palliative care as end-of-life care.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:50Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
Related Concept Videos
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...